Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability. Its novel approach addressescurrent challenges associated with both chemoresistance in cancer and effective systemic delivery of miRNA mimics.

Biotechnology

Therapeutics

Curamir Therapeutics

Org chart

Similar companies